对二进制结果的基于手臂与基于对比的网络元分析进行审查和比较 - 了解它们的差异和局限性
Haitao Chu1,2, Lifeng Lin3, Zheng Wang2
1Statistical Research and Data Science Center, Pfizer Inc., New York, New York, USA.
概括
网络元分析 (NMA) 将多种治疗方法进行比较. 本研究详细介绍了基于对比度 (CB-NMA) 和基于手臂 (AB-NMA) 的方法,强调了它们的假设和强有力的证据合成的潜在偏见.
科学领域:
- 生物统计学 生物统计学
- 证据综合 证据综合
- 临床流行病学临床流行病学
背景情况:
- 网络元分析 (NMA) 整合了直接和间接的证据,用于比较多种干预措施,增强治疗指南的支持.
- 存在两个主要的NMA方法:基于对比度 (CB-NMA) 和基于臂的 (AB-NMA),每一个都有不同的建模假设和估计.
研究的目的:
- 审查,总结和阐述CB-NMA和AB-NMA的假设,差异和优点/缺点.
- 为了解决AB-NMA可能不会保留试验随机化的批评,可能会偏见相对效应估计.
主要方法:
- 基于对比度和基于臂的网络元分析模型的比较分析.
- 详细阐述每个NMA方法的基础统计假设和数据生成机制.
主要成果:
- CB-NMA专注于固定拦截的相对效应,而AB-NMA允许随机拦截的绝对和相对效应.
- 一个关键的AB-NMA批评是它有可能通过不完全保留试验随机化来引入偏见,特别是当相对效应是可转移的.
结论:
- CB-NMA和AB-NMA都有明显的优缺点;没有一种方法是普遍优越的.
- 建议使用CB-NMA和AB-NMA作为补充敏感性分析,以全面了解治疗比较和证据总和.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
McNemar's Test
206
McNemar's Test is a nonparametric statistical test used to determine if there is a significant difference in proportions between two related groups when the outcome is binary (e.g., yes/no, success/failure). It is beneficial when we have paired data, such as pre-test/post-test designs, where the same subjects are measured under two different conditions. The test is named after the statistician Quinn McNemar, who introduced it in 1947. It is commonly used in situations where subjects are...
206
Multiple Comparison Tests
3.9K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
3.9K
The Mantel-Cox Log-Rank Test
348
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
348
Hazard Ratio
111
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
111


